Proposed mechanisms of action include inhibition of transforming growth factor-β1 (TGF-β1) expression [25] and amelioration of oxidative stress [26], which have been shown to be final common mediators of renal injury in diabetes [27]. This evidence concerns the gene TGFB1 and diabetes mellitus.